Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Personal Injury Law

: Philadelphia Personal Injury Lawyer

More PML Cases With Tysabri

By Jamie Sheller

ADVERTISEMENTS

According to the FDA, there have been 3 new cases of a potentially deadly brain infection linked to Tysabri, a multiple sclerosis drug. Since mid-2006, 13 cases of progressive multifocal leukoencephalopathy (PML) have been reported with Tysabri. PML is a rare infection, but the longer patients continue using Tysabri, they appear to be at an increased risk for developing PML. Biogen Idec Inc. and Elan Corp. PLC market Tysabri for treating multiple sclerosis and Crohn's disease. Tysabri was introduced to the market in 2004 and then removed in 2005, following reports of PML. In July 2006, Tysabri was reintroduced.

If you or a family member has developed PML while using Tysabri, contact Sheller, P.C., to discuss your legal rights. Sheller lawyers are investigating potential litigation for people injured by Tysabri. Sheller, P.C. has a long history of successfully representing individuals and classes of people who have been injured by pharmaceuticals.

Originally posted at InjuryBoard by Jamie Sheller

Full post as published by Philadelphia Personal Injury Lawyer on September 24, 2009 (boomark / email).